Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Net-Borrowings" stands at 2.98 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2023.
Merck & Company Inc's third quarter result of 5.98 Billion USD for the item "Net Borrowings" represents an increase of 12,350.00 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 5.98 Billion USD for the item "Net Borrowings" represents an increase of 597,700.00 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 2.98 Billion USD for the item "Net Borrowings" represents an increase of 199.77 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.72 Billion United States Dollars compared to the value the year prior.
The 1 year change is 11.72 Billion United States Dollars.
The 3 year change is -0.532 Billion United States Dollars.
The 5 year change is 0.649 Billion United States Dollars.
The 10 year change is 6.48 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Borrowings | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Borrowings | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Borrowings | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Borrowings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Borrowings | 280,205,508,085.11 |